STUDI SULLO SCOMPENSO CARDIACO
In questa pagina sono raccolti molti degli studi, farmacologici e non,
effettuati su pazienti con scompenso cardiaco o comunque su pazienti con
disfunzione ventricolare sinistra. Gli studi sono suddivisi per tipo di farmaco
o di trattamento utilizzato con una parte finale in cui sono raccolti quelli
che non rientrano specificamente in nessuna delle categorie precedenti. Per
avere maggiori informazioni circa questi studi oltre a consultare MEDLINE,
consiglio il sito: http://www.cardiosource.com/. Si
tratta di un sito in collegamento con l’AMERICAN COLLEGE OF CARDIOLOGY, dove è
possibile consultare gli indici di molte riviste interessanti (nel caso si sia
abbonati ad una di queste è possibile consultarla full-text), inoltre nella sezione
TRIAL è possibile avere chiare e concise informazioni (tipo di studio,
popolazione, farmaco, risultati ecc.) su circa 600 studi effettuati ed in
corso, oltre ad avere i riferimenti bibliografici sugli studi già pubblicati.
All’ HOME PAGE è necessario registrarsi, la registrazione è gratuita anche se
ciò limita l’accesso delle riviste come detto sopra alla sola consultazione
degli indici.
- AIRE
Acute Infarction Ramipril Efficacy study
- ANZ
Australia and New Zealand heart failure study
- ATLAS
Assessment of Treatment with Lisinopril And Survival
- CASSIS
Czech And Slovak Spirapril Intervention Study
- CONSENSUS
COoperative North Scandinavian ENalapril SUrvival Study
- ESTIC
Estudio Supervivencia en el Tratamiento de la Insufficiencia Cardiaca
- FEST
Fosinopril Efficacy/Safety Trial
- Hy-C
Hydralazine Captopril trial
- MHFT
Munich Mild Heart Failure Trial
- NETWORK
NETWORK
- RAAS
Randomised Angiotensin receptor Antagonist - ACE inhibitor Study
- RADIANCE
Randomized Assessment of the effect of Digoxin on Inhibitors of the
ANgiotensin-Converting Enzyme study
- RESOLVD
Randomized Evaluation of Strategies for Left Ventricular Dysfunction
- SAVE
Survival And Ventricular Enlargement Study
- SOLVD
Studies Of Left Ventricular Dysfunction
- VHeFT III
Vasodilator Heart Failure Trial III
- CHARM
Candesartan in Heart Failure-Assessment of Reduction in Mortality and
morbidity
- ELITE
Evaluation of Losartan in the Elderly Study
- ELITE II
The Losartan heart failure survival study-ELITE II
- OPTIMAAL
OPtimal Trial In Myocardial infarction with Angiotensin II Antagonist
Losartan
- RAAS
Randomised Angiotensin receptor Antagonist - ACE inhibitor Study
- RESOLVD
Randomized Evaluation of Strategies for Left Ventricular Dysfunction
- SPICE
Study of Patients Intolerant of Converting Enzyme inhibitors
- VAL-HeFT
Valsartan in Heart Failure Trial
- VALIANT
VALsartan In Acute myocardial iNfarcTion
- HELAS
Heart failure Long-term Antithrombotic Study
- WASH
Warfarin Aspirin Study in Heart failure
- BEST
Beta-blocker Evaluation Survival Trial
- BEST-ICD
BEta-blocker STrategy plus Implantable Cardioverter Defibrillator trial
- CAPRICORN
Carvedilol Post-infaRct survIval ContRolled evaluatioN
- CARMEN
Carvedilol ACE inhibitor Remodelling Mild heart failure EvaluatioN
- CIBIS
Cardiac Insufficiency BIsoprolol Study
- CIBIS II
Cardiac Insufficiency Bisoprolol Study II
- COMET
Carvedilol Or Metoprolol European Trial
- COPERNICUS
CarvedilOl ProspEctive RaNdomIzed CUmulative Survival Trial
- MDC
Metoprolol in Dilated Cardiomyopathy trial
- MERIT-HF
MEtoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure
- MOCHA
Multicenter Oral Carvedilol Heart failure Assessment
- PRECISE
Prospective Randomized Evaluation of CarvedIlol on Symptoms and Exercise
- DIDI
DIltiazem in DIlated cardiomyopathy
- MDPIT
Multicenter Diltiazem Post-Infarction Trial
- PRAISE
Prospective Randomized AmlodIpine Survival Evaluation
- PRAISE I
Prospective Randomised Amlodipine Survival Evaluation I
- PRAISE II
Prospective Randomised Amlodipine Survival Evaluation II
- VHeFT III
Vasodilator Heart Failure Trial III
- AVID
Antiarrhytmics Versus Implantable Defibrillators
- BEST-ICD
BEta-blocker STrategy plus Implantable Cardioverter Defibrillator trial
- DEFINITE
DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluatiion
- MADIT
Multicenter Autonomic Defibrillator Implantation Trial
- MADIT II
Multicenter Autonomic Defibrillator Implantation Trial II
- DIG
Digitalis Investigation Group Trial
- DIMT
Dutch Ibopamine Multicenter Trial
- ESTIC
Estudio Supervivencia en el Tratamiento de la Insufficiencia Cardiaca
- FACET
Flosequinan-ACE inhibitor Trial
- PRIME II
Prospective Randomised study of Ibopamine on Mortality and Efficacy II
- PROFILE
Effect of Flosequinan on survival in Chronic Heart failure
- PROMISE
Prospective RandOmized MIlrinone Survival Evaluation trial
- RADIANCE
Randomized Assessment of the effect of Digoxin on Inhibitors of the
ANgiotensin-Converting Enzyme study
- REFLECT
Randomized Evaluation of FLosequinan on ExerCise Tolerance study
- Vesnarinone Trial
Vesnarinone Trial
- Vesnarinone Trial Study
Group
Vesnarinone Trial Study Group
- Hy-C
Hydralazine Captopril trial
- V-HeFT I
Vasodilator-Heart Failure Trial I
- V-HeFT II
Vasodilator-Heart Failure Trial II
- AHFMS
Auckland Heart Failure Management Study
- CABG Patch
Coronary Artery Bypass Graft Patch Trial
- CHF STAT
Congestive Heart Failure: Survival Trial of Antiarrhythmic Therapy
- DIAMOND
Danish Investigations of Arrhythmias and Mortality ON Dofetilide
- ENABLE
ENdothelin Antagonist Bosentan for Lowering cardiac Events
- FIRST
Flolan International Randomized Survival Trial
- GESICA
Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina
- MOXCON
MOXonidine in CONgestive heart failure
- MUSTT
Multicenter UnSustained Tachycardia Trial
- RALES
Randomized Aldactone Evaluation Study
- REACH-1
Research on Endothelin Antagonism in Chronic Heart failure
- REMATCH
Randomized Evaluation of Mechanical Assistance for Treatment of Chronic
Heart Failure
- RENAISSANCE
Randomized Etanercept North AmerIcan Strategy to Study ANtagonism of
CytokinEs
- SCD-HeFT
Sudden Cardiac Death in Heart Failure
- SPIC
Studio Policentrico Italiano Cardiomiopatie
- TACTICS
Thrombolysis And Counterpulsation To Improve Cardiogenic Shock survival
- VERBS
Ventricular Endocardial Right Bifocal Stimulation
- VMAC
Vasodilatation in the Management of Acute Congestive Failure